Cultural advice

The Australian National University acknowledges, celebrates and pays our respects to the Ngunnawal and Ngambri people of the Canberra region and to all First Nations Australians on whose traditional lands we meet and work, and whose cultures are among the oldest continuing cultures in human history.

Aboriginal and Torres Strait Islander peoples are advised that ANU Library collections may include images, names, voices, and other representations of deceased persons.

Material in the collection may contain terms, language or views that reflect the period in which the item was created and may be considered inappropriate today.

Correspondence: Reply to Cohen and Denning

dc.contributor.authorCollignon, Peter
dc.contributor.authorConly, John M
dc.contributor.authorAndremont, Antoine
dc.contributor.authorMcEwen, Scott A.
dc.contributor.authorAidara-Kane, Awa
dc.date.accessioned2019-11-26T00:43:01Z
dc.date.issued2017-04-01
dc.date.updated2020-07-05T08:18:39Z
dc.description.abstractTo the Editor — We agree with Cohen and Denning [1] that the large-scale use of antifungals in agriculture on crops is a potential threat to human populations, because resistant fungi that develop can be transmitted to humans [2]. We also agree that the issue of antimicrobial resistance should not be confined solely to the large-scale use of antibiotics. Overuse of antifungals (especially azole use) is an important issue. We also need to be concerned about possible large-scale use of antivirals in agriculture—for example, reports of amantidine and other anti-influenza antiviral use in poultry in China because of H5N1 outbreaks in fowl flocks [3, 4]—and then with the resultant risk of influenza strains developing resistance to antivirals if acquired by swine and/or humans.
dc.description.sponsorshipJ. M. C. has received grants from Alberta Innovates-Health Solutions, personal fees and nonfinancial support from Pfizer, nonfinancial support from bioMérieux, and other support from the National Collaborating Centre for Infectious Diseases (Canada). A. A. has received personal fees from the Davoltera company (within the frame of the French law for innovation and research) and Cepheid and has received grants from the Agence Nationale pour le Recherche and from the European Union FP7 program. S. A. M. has been granted contracts from Health Canada and the Ontario Ministry of Agriculture, Food and Rural Affairs.en_AU
dc.format.extent2 pages
dc.format.mimetypeapplication/pdfen_AU
dc.identifier.issn1058-4838en_AU
dc.identifier.urihttp://hdl.handle.net/1885/186643
dc.language.isoen_AUen_AU
dc.publisherOxford University Press
dc.rights© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America.
dc.sourceClinical Infectious Diseases
dc.titleCorrespondence: Reply to Cohen and Denning
dc.typeJournal article
local.bibliographicCitation.issue7en_AU
local.bibliographicCitation.lastpage988en_AU
local.bibliographicCitation.startpage987en_AU
local.contributor.affiliationCollignon, Peter J., College of Health and Medicine, The Australian National Universityen_AU
local.contributor.affiliationConly, John M, University of Calgaryen_AU
local.contributor.affiliationAndremont, Antoine, University of Paris-Diderot Medical Schoolen_AU
local.contributor.affiliationMcEwen, Scott A. , University of Guelphen_AU
local.contributor.affiliationAidara-Kane, Awa, World Health Organizationen_AU
local.contributor.authoruidCollignon, Peter, u1845890en_AU
local.description.embargo2037-12-31
local.description.notesImported from ARIESen_AU
local.identifier.absfor060504 - Microbial Ecologyen_AU
local.identifier.absfor110303 - Clinical Microbiologyen_AU
local.identifier.absseo920106 - Endocrine Organs and Diseases (excl. Diabetes)en_AU
local.identifier.absseo920199 - Clinical Health (Organs, Diseases and Abnormal Conditions) not elsewhere classifieden_AU
local.identifier.ariespublicationu5234101xPUB50en_AU
local.identifier.citationvolume64en_AU
local.identifier.doi10.1093/cid/cix061en_AU
local.identifier.essn1537-6591en_AU
local.identifier.scopusID2-s2.0-85018305198
local.identifier.thomsonID3.9744E+11
local.publisher.urlhttp://www.oxfordjournals.org/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
01 Collignon P J et al Reply to Cohen 2017.pdf
Size:
199.95 KB
Format:
Adobe Portable Document Format
Description: